Intrapericardial Triamcinolone Instillation for Recurrent Pericardial Effusion in Pediatric Patients: A Review of

Abhiram Reddy1, Daniel Peck1, Daniel Cortez2

  • 1Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Masonic Children's Hospital, 2450 Riverside Ave, Academic Office Building (AOB), 4th floor, # AOB-407, Minneapolis, MN, 55454, USA.

Insights

Intrapericardial triamcinolone shows promise for treating recurrent pericardial effusion in children. This study found it effective and safe as an adjunctive therapy for pediatric patients with idiopathic pericardial effusions.

Area of Science:

  • Pediatric Cardiology
  • Pharmacology
  • Medical Case Studies

Background:

  • Recurrent pericardial effusion in children lacks extensive research regarding intrapericardial triamcinolone.
  • The efficacy and safety of intrapericardial triamcinolone in pediatric patients are not well-defined.

Purpose of the Study:

  • To evaluate the efficacy, side effects, and safety of intrapericardial triamcinolone in pediatric patients with recurrent idiopathic pericardial effusions.
  • To expand the understanding of this treatment in a pediatric population.

Main Methods:

  • Retrospective case series of nine pediatric patients treated with intrapericardial triamcinolone.
  • Data collected from 2015 to 2025 at a single center.
  • Efficacy assessed via echocardiograms and symptom monitoring; side effects documented.

Main Results:

  • Five patients achieved resolution of pericardial effusion; three showed improvement.
  • One patient experienced relapse; five had transient, steroid-like side effects.
  • Two patients died due to underlying conditions, not treatment.

Conclusions:

  • Intrapericardial triamcinolone appears to be a safe and effective adjunctive treatment for pediatric recurrent idiopathic pericardial effusion.
  • Further research is warranted to fully characterize its long-term outcomes and safety profile in children.

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...